Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Fitzharris BM"'
Autor:
Alexander Guminski, Fitzharris Bm, Jonathan Cebon, Wen-Jen Hwu, Georgina V. Long, Michael B. Jameson, Blanca Homet Moreno, Andrew G. Hill, Alexander M. Menzies, Antoni Ribas, Nageatte Ibrahim, Victoria Atkinson, Richard F. Kefford, Catriona M. McNeil, F. Stephen Hodi, Matteo S. Carlino, Haiyan Wu, Michael B. Atkins, John A. Thompson
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 26(19)
Purpose: Combination therapy with reduced-dose programmed death 1 inhibitor plus standard-dose cytotoxic T-lymphocyte–associated antigen 4 inhibitor demonstrated efficacy, but substantial toxicity, in melanoma. We present long-term results of part
Autor:
M. Mccrystal, Jennifer G. Smith, J F Bishop, Kelly-Anne Phillips, Ian N. Olver, Fitzharris Bm, M. Friedlander, J. Joughin, B. Evans
Publikováno v:
Scopus-Elsevier
Background : Until recently there has been no effective therapy for patients with relapsed ovarian carcinoma following standard platinum based chemotherapy. Paclitaxel has recently been approved for clinical use in this malignancy. Aims : To evaluate
Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors
Publikováno v:
Journal of Clinical Oncology. 10:1609-1614
PURPOSE Elevated total serum cholesterol levels have been reported recently in a group of patients with metastatic testicular cancer after treatment with cisplatin combination chemotherapy. We have studied the lipid profile of a similar group of pati
Publikováno v:
Australian and New Zealand Journal of Medicine. 20:657-662
In patients with cancer treated with cisplatin, carboplatin or methotrexate creatinine clearance calculated using the Cockcroft-Gault formula was compared with measured clearance and with the glomerular filtration rate. In 106 patients the average sq
Publikováno v:
Australian and New Zealand journal of medicine. 24(4)
Aim: To determine the incidence of second malignant neoplasms in patients treated for Hodgkin's disease. Methods: The records were reviewed of all patients receiving primary treatment for Hodgkin's disease at the Oncology Service, Christchurch Hospit
Publikováno v:
Cancer chemotherapy and pharmacology. 26(3)
For assessment of the ototoxic potential of carboplatin [cis-diammine-1,1-cyclobutane dicarboxylate platinum(II); CBDCA], pure-tone audiograms were evaluated in 27 patients receiving a total of 119 doses of carboplatin in the range of 300-400 mg/m2.
Publikováno v:
Hematological oncology. 7(5)
A retrospective study of 163 patients with Hodgkin's disease treated between 1969 and 1987 was performed to identify adverse prognostic factors. One hundred and thirty-five patients (83 per cent) attained a complete remission and 42 (31 per cent) of
Autor:
R. Wines, John A. Levi, Fitzharris Bm, B. M. Colls, M. H. N. Taitersall, Chris Atkinson, G. Coorey, Woods Rl, Derek Raghavan, C. Farrell
Publikováno v:
British journal of urology. 61(6)
Forty-six patients with clinical stage I testicular non-seminomatous germ cell tumours were followed up according to a protocol of active surveillance between 1979 and 1987. The median follow-up time was 40+ months. Thirteen patients (28%) relapsed,
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.